Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesWomens ImagingUterine fibroid assessment differs by imaging techniqueMRI and ultrasound differ in mapping uterine fibroids in women undergoing laparoscopic-assisted robotic myomectomy.MRISocieties host events for MR Safety WeekEconomicsACR releases impact tables for 2027 MPFS proposed ruleMolecular ImagingSPECT/CT viable over PET/CT for high-risk prostate cancer stagingUltrasoundUltrasound MinnieCast, Episode 13: Who owns echocardiography?
